2021 annual financial data
Corvus Pharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -38,630,000 USD and net income was -43,241,000 USD.
Operating cash flow was -36,715,000 USD.
Get free Corvus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -38,630,000 USD
- Net income
- -43,241,000 USD
- Operating cash flow
- -36,715,000 USD